RECENT PAST NEWS IN MDR-TB

Updated WHO 6-Month MDR-TB Regimen

Possible new method identified to assess severity of TB infection

Drug-resistant TB: Rollout of shorter regimen hits a snag in South Africa

Promising new target for tuberculosis treatment

Genomic signatures of pre-resistance in Mycobacterium tuberculosis

New TB Funding Trends Report Finds that Funding for TB Research in 2020 Reached Only US$915 Million

South Africa sets another example of success in beating tuberculosis

Global individual patient data platform for drug-resistant tuberculosis treatment

UNITE4TB: a new consortium for clinical drug and regimen development for TB.

Assessment of epi and genetic and clinical outcomes of resistance to bedaquiline

Clinical trial results offer hope to DR-TB patients with short, effective treatment

Largest ever global study of tuberculosis identifies genetic causes of drug resistance

EndTB clinical trial for multi drug-resistant TB completes enrollment

Joint GLI-GDI Workshop: access to diagnostics, treatment, and care to end TB

Watch our most recent webinar

Fighting tuberculosis with medication, mental health, and social support

Innovative tools take aim at antibiotic-resistant microbes

How COVID is derailing the fight againstHIV, TB, and Malaria

New Trial Shows Effectiveness of BPaL Regimen for Highly Drug-Resistant TB

WHO 2021 Genetic Susceptibility Testing Statement